A-to-I RNA editing

ADAR1: A Potential Target in Tumor Immunity

ADAR1 is an important RNA-editing enzyme that catalyzes adenosine-to-inosine (A-to-I) editing in double-stranded RNA (dsRNA), reducing the recognition of endogenous dsRNA by nucleic acid-sensing systems such as MDA5, PKR, and ZBP1. Tumor cells can exploit ADAR1 to maintain RNA immune tolerance, ...